• 179 Citations
  • 5 h-Index
20042018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maria Isabel Alvarez De Celis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 26 Similar Profiles
Follicular Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Mitoxantrone Medicine & Life Sciences
Vincristine Medicine & Life Sciences
Prednisone Medicine & Life Sciences
Blast Crisis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2018

  • 179 Citations
  • 5 h-Index
  • 13 Article

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

Iannitto, E., Bellei, M., Amorim, S., Ferreri, A. J. M., Marcheselli, L., Cesaretti, M., Haioun, C., Mancuso, S., Bouabdallah, K., Gressin, R., Tripodo, C., Traverse-Glehen, A., Baseggio, L., Zupo, S., Stelitano, C., Castagnari, B., Patti, C., Alvarez, I., Liberati, A. M., Merli, M. & 11 others, Gini, G., Cabras, M. G., Dupuis, J., Tessoulin, B., Perrot, A., Re, F., Palombi, F., Gulino, A., Zucca, E., Federico, M. & Thieblemont, C., Dec 2018, In : British Journal of Haematology. 183, 5, p. 755-765 11 p.

Research output: Contribution to journalArticle

Lymphoma
Confidence Intervals
Febrile Neutropenia
Splenectomy
Infection
1 Citation (Scopus)

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

Iannitto, E., Bellei, M., Amorim, S., Ferreri, A. J. M., Marcheselli, L., Cesaretti, M., Haioun, C., Mancuso, S., Bouabdallah, K., Gressin, R., Tripodo, C., Traverse-Glehen, A., Baseggio, L., Zupo, S., Stelitano, C., Castagnari, B., Patti, C., Alvarez, I., Liberati, A. M., Merli, M. & 11 others, Gini, G., Cabras, M. G., Dupuis, J., Tessoulin, B., Perrot, A., Re, F., Palombi, F., Gulino, A., Zucca, E., Federico, M. & Thieblemont, C., 2018, In : British Journal of Haematology. 183, 5, p. 755-765 11 p.

Research output: Contribution to journalArticle

Lymphoma
Confidence Intervals
Febrile Neutropenia
Splenectomy
Infection
1 Citation (Scopus)

A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up

Bari, A., Marcheselli, R., Marcheselli, L., Alvarez, I., Pozzi, S., Ferri, P., Lazzaro, A., Fragasso, A., Neri, S., Baldini, L., Carella, A. M., Angrilli, F., Guariglia, R., Buda, G., Stelitano, C. & Sacchi, S., Nov 4 2016, (Accepted/In press) In : Acta Haematologica. p. 7-14 8 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Disease-Free Survival
Drug Therapy
Survival
Feasibility Studies

A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up

Bari, A., Marcheselli, R., Marcheselli, L., Alvarez De Celis, M. I., Pozzi, S. S., Ferri, P., Lazzaro, A., Fragasso, A., Neri, S., Baldini, L., Carella, A. M., Angrilli, F., Guariglia, R., Buda, G., Stelitano, C. & Sacchi, S., Nov 4 2016, (Accepted/In press) In : Acta Haematologica. p. 7-14 8 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Disease-Free Survival
Drug Therapy
Survival
Feasibility Studies

A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up

Bari, A., Marcheselli, R., Marcheselli, L., Alvarez De Celis, M. I., Pozzi, S., Ferri, P., Lazzaro, A., Fragasso, A., Neri, S., Baldini, L., Carella, A. M., Angrilli, F., Guariglia, R., Buda, G., Stelitano, C., Sacchi, S. & Gruppo Italiano Studio Linfomi (GISL), Nov 4 2016, In : Acta Haematologica. 137, 1, p. 7-14 8 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Disease-Free Survival
Drug Therapy
Survival
Feasibility Studies